8:00 am Registration & Morning Refreshments
8:50 am Chair’s Opening Remarks
Tapping into Ingredient Availability & Regulatory Approval to Promote Effective Application for Infant Formula Products
9:00 am Case-Study: Outlining Safety Packages for Specific Bioactive Ingredients to Lay Down a Regulatory Framework & Product Timeline Horizons
Synopsis
- Discussing how to curate a robust safety package from pre-clinic and clinic to regulators to streamline ingredient approval
- Understanding what a bioactive compound from a regulatory perspective is to speak to and diffuse objections
- Setting up a framework for approval as an ingredient provider to assess and eradicate risk ahead of time when working with unapproved bioactives
9:30 am Panel Discussion: Discussing the Regulatory Framework & Market Access Approach for Ingredient Providers & Formula Manufacturer Dynamic to Streamline Approval
Synopsis
- Unpicking market access strategy including data packages and ingredient characterization to pin-point potential challenges and solutions
- Enhancing robustness of market access strategies ahead of regulatory and partner collaboration to promote stakeholder engagement
- Exploring experiment optimization strategies to present evidentiary data to help influence partnership decisions
10:15 am Morning Break
Propelling Forth Novel & Innovative Bioactives to Discover Unexplored Opportunity & Direct Products of the Future
11:00 am Discussing the Evolution of Technology for Cellular and Precision Fermentation-Derived Ingredients as a Gateway to Sustainability & Economic Feasibility
Synopsis
- Tapping into the changing world of infant formula HMOs vs traditional production to fill in market gaps
- Outlining differences between cell-based and fermentation approaches to pin-point areas of opportunity
- Developing on proof of concept for cell-based and exosome technologies to pinpoint and exploit major successes for application
11:30 am Panel Discussion: Keeping Up with the Latest & Greatest in Discussing Opinions & Future Movements on Novel Technologies
Synopsis
- Pin-pointing novel bioactive sources and technologies with the most translational promise and consumer benefit
- Understanding best prioritize bioactives within the portfolio according to current demand
- Discussing the extent of potential for cutting-edge cell-based and novel fermentation technologies reach new horizons for infant formula
12:15 pm Networking Lunch
Streamlining from Proof of Concept to Technical Implementation for Novel Formulae
1:15 pm Case Study: Building a Mammary Biomanufacturing Platform to Explore Novel Avenues For Ingredient Production
Synopsis
- Looking into BIOMILQ’s biomanufacturing platform that utilizes the unique potential of human mammary cells to produce human milk ingredients for the betterment of human health
- Communicating the rationale behind using bioactive approaches to encourage innovation and shape the future of early life nutrition
- Demonstrating proof of concept for cell-based technologies to support collaboration and streamline investments
1:45 pm Case Study: Building Trust Surrounding Precision Fermentation Approaches to Shift Traditional Mindsets & Explore Novel Avenues for Ingredient Production
Synopsis
- Displaying novel approaches and innovative technologies to showcase future horizons for formula applications
- Communicating the rationale behind using non-standard and non-approved bioactive approaches to encourage innovation
- Demonstrating proof of concept for humanization of formula ingredients to engage support for experimental trials and regulatory plans
2:15 pm Afternoon Break
Leveraging Research Insights to Inform Efficacy Demonstrations Fit for Proof of Product Claims
2:45 pm Securing Industry & Academic Collaboration to Effectively Transition from Concept to Proof of Viability
Synopsis
- Learning how to promote your technologies to academia and speak to desired interests to promote engagement
- Examining what’s desired regarding IP discussions and publications to uncover what good looks like from an academic perspective
- Tackling translational science from preclinical trials to infant physiology to exploit key benefits through data displays and market delivery
3:15 pm Enhancing Preclinical Efficacy for Bioactive Data Demonstration & Displaying Rationale Behind Decisions
Synopsis
- Addressing critical growth parameters and models to support translational science and efficacy
- Discussing the concept of human milk as a biological system (BEGIN project): assessing bioactive ingredients in conjunction vs singular analysis
- Exploring examples of outcomes with single vs. combined ingredients (probiotics/ HMO or HMO/HMO) to observe combinatorial effects in preclinical trials